Core Viewpoint - Goldman Sachs reports that WuXi AppTec's order momentum remains strong, with robust customer demand, particularly from U.S. clients [1] Group 1: Financial Performance - The company aims for a 45% year-on-year revenue growth target, which is on track [1] - Gross margin in the second half of the year may be lower than in the first half [1] Group 2: Business Development - The company is actively negotiating contracts for its Singapore facility, expecting to sign several agreements by the end of the year [1] - Revenue contribution from the Singapore facility is expected to be limited until 2027 due to capacity expansion timelines [1] Group 3: Operational Expansion - The company is progressing with capacity and workforce expansion as planned, with ongoing recruitment efforts [1]
大行评级丨高盛：药明合联订单势头持续强劲且客户需求稳健 目标价63.3港元